The DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.
Nuclear factor-κB in cancer development and progression
Abstract
Nuclear factor-kappaB (NF-kappaB) transcription factors and the signalling pathways that activate them are central coordinators of innate and adaptive immune responses. More recently, it has become clear that NF-kappaB signalling also has a critical role in cancer development and progression. NF-kappaB provides a mechanistic link between inflammation and cancer, and is a major factor controlling the ability of both pre-neoplastic and malignant cells to resist apoptosis-based tumour-surveillance mechanisms. NF-kappaB might also regulate tumour angiogenesis and invasiveness, and the signalling pathways that mediate its activation provide attractive targets for new chemopreventive and chemotherapeutic approaches.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“When NF-κB is activated, transcription of proinflammatory immune response genes such as Tnfα and Il1 occurs, which leads to translation and production of proinflammatory cytokines that serve to coordinate the inflammatory response (Karin, 2006).”
From Sleep health: Reciprocal regulation of sleep and innate immunity (2017) · cites this paper as Karin, 2006
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Pathogen Recognition and Innate Immunity
Akira, S., Uematsu, S., & Takeuchi, O. (2006) · Cell · doi:10.1016/j.cell.2006.02.015 · Cited by 11,976
Inflammation and cancer: back to Virchow?
Balkwill, F., & Mantovani, A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04046-0 · Cited by 7,746
Phosphorylation meets ubiquitination: the control of NF-κB activity
Karin, M., & Ben-Neriah, Y. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.621 · Cited by 4,766
Self-citationDanial, N. N., & Korsmeyer, S. J. (2004) · Cell · doi:10.1016/s0092-8674(04)00046-7 · Cited by 4,651
Toll-like receptors and innate immunity
Medzhitov, R. (2001) · Nature Reviews Immunology · doi:10.1038/35100529 · Cited by 4,308
NF-κB regulation in the immune system
Li, Q., & Verma, I. M. (2002) · Nature Reviews Immunology · doi:10.1038/nri910 · Cited by 4,007
Missing Pieces in the NF-κB Puzzle
Ghosh, S., & Karin, M. (2002) · Cell · doi:10.1016/s0092-8674(02)00703-1 · Cited by 3,638
Self-citationNF-κB: linking inflammation and immunity to cancer development and progression
Karin, M., & Greten, F. R. (2005) · Nature reviews. Immunology · doi:10.1038/nri1703 · Cited by 3,175
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Items 401–500 of 1,010
Cao, Y., Luo, J., & Karin, M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706728104 · Cited by 149
Self-citationBuhrmann, C., Shayan, P., Kraehe, P., Popper, B., Goel, A., & Shakibaei, M. (2015) · Biochemical Pharmacology · doi:10.1016/j.bcp.2015.08.105 · Cited by 149
Reduced cell proliferation by IKK2 depletion in a mouse lung-cancer model
Xia, Y., Yeddula, N., Leblanc, M., Ke, E., Zhang, Y., Oldfield, E., Shaw, R. J., & Verma, I. M. (2012) · Nature Cell Biology · doi:10.1038/ncb2428 · Cited by 152
González-Ramos, R., Defrère, S., & Devoto, L. (2012) · Fertility and Sterility · doi:10.1016/j.fertnstert.2012.06.021 · Cited by 149
Molecular Pathways for Cancer Chemoprevention by Dietary Phytochemicals
Tan, A. C., Konczak, I., Sze, D., & Ramzan, I. M. (2011) · Nutrition and Cancer · doi:10.1080/01635581.2011.538953 · Cited by 150
Zhang, Z., Huang, L., Zhao, W., & Rigas, B. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4204 · Cited by 150
Basic properties and molecular mechanisms of exogenous chemical carcinogens
Irigaray, P., & Belpomme, D. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp252 · Cited by 153
Critical role of NF-κB in pancreatic cancer
Prabhu, L., Mundade, R., Korc, M., Loehrer, P. J., & Lu, T. (2014) · Oncotarget · doi:10.18632/oncotarget.2624 · Cited by 153
Meunier, J., & Hayashi, T. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.160960 · Cited by 148
ROS and Brain Gliomas: An Overview of Potential and Innovative Therapeutic Strategies
Rinaldi, M., Caffo, M., Minutoli, L., Marini, H. R., Abbritti, R. V., Squadrito, F., Trichilo, V., Valenti, A., Barresi, V., Altavilla, D., et al. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17060984 · Cited by 151
Rohwer, N., Dame, C., Haugstetter, A., Wiedenmann, B., Detjen, K. M., Schmitt, C. A., & Cramer, T. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012038 · Cited by 152
NF-κB Directly Regulates Fas Transcription to Modulate Fas-mediated Apoptosis and Tumor Suppression
Liu, F., Bardhan, K., Yang, D., Thangaraju, M., Ganapathy, V., Waller, J. L., Liles, G. B., Lee, J. R., & Liu, K. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.356279 · Cited by 154
RNA fate determination through cotranscriptional adenosine methylation and microprocessor binding
Knuckles, P., Carl, S. H., Musheev, M. U., Niehrs, C., Wenger, A., & Bühler, M. (2017) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.3419 · Cited by 152
Qing, G., Yan, P., & Xiao, G. (2006) · Cell Research · doi:10.1038/sj.cr.7310109 · Cited by 153
Digitoxin as an anticancer agent with selectivity for cancer cells: possible mechanisms involved
López-Lázaro, M. (2007) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.11.8.1043 · Cited by 145
Yang, L., Inokuchi, S., Roh, Y. S., Song, J., Loomba, R. S., Park, E. J., & Seki, E. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.01.056 · Cited by 145
Nuclear factor κB transcription factors are coexpressed and convey a poor outcome in ovarian cancer
Annunziata, C. M., Stavnes, H. T., Kleinberg, L., Berner, A., Hernandez, L. F., Birrer, M. J., Steinberg, S. M., Davidson, B., & Kohn, E. C. (2010) · Cancer · doi:10.1002/cncr.25190 · Cited by 145
Zimmerman, N. P., Vongsa, R. A., Wendt, M. K., & Dwinell, M. B. (2008) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20480 · Cited by 147
Cindrová‐Davies, T. (2009) · Placenta · doi:10.1016/j.placenta.2008.11.020 · Cited by 147
Bortezomib-Resistant Nuclear Factor-κB Activity in Multiple Myeloma Cells
Markovina, S. S., Callander, N. S., O’Connor, S. L., Kim, J., Werndli, J. E., Raschko, M., Leith, C. P., Kahl, B. S., Kim, K., & Miyamoto, S. (2008) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0108 · Cited by 148
DAMPs, ageing, and cancer: The ‘DAMP Hypothesis’
Huang, J., Xie, Y., Sun, X., Zeh, H. J., Kang, R., Lotze, M. T., & Tang, D. (2015) · Ageing Research Reviews · doi:10.1016/j.arr.2014.10.004 · Cited by 144
Jung, J., Park, S., Lee, S., Seo, M., Trosko, J. E., & Kang, K. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028068 · Cited by 145
Gupta, S. C., Kim, J. H., Kannappan, R., Reuter, S., Dougherty, P. M., & Aggarwal, B. B. (2011) · Experimental Biology and Medicine · doi:10.1258/ebm.2011.011028 · Cited by 146
Upregulation of Twist-1 by NF-κB Blocks Cytotoxicity Induced by Chemotherapeutic Drugs
Pham, C. G., Bubici, C., Zazzeroni, F., Knabb, J. R., Papa, S., Kuntzen, C., & Franzoso, G. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01219-06 · Cited by 144
Immunological Mechanisms in Inflammation-Associated Colon Carcinogenesis
Hirano, T., Hirayama, D., Wagatsuma, K., Yamakawa, T., Yokoyama, Y., & Nakase, H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093062 · Cited by 147
The Rise of Gastrointestinal Cancers as a Global Phenomenon: Unhealthy Behavior or Progress?
Jardim, S. R., de Souza, L. M. P., & de Souza, H. S. P. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20043640 · Cited by 157
Cross talk between stimulated NF-κB and the tumor suppressor p53
Schneider, G., Henrich, A., Greiner, G., Wolf, V, Lovas, A., Wieczorek, M., Wagner, T., Reichardt, S., von Werder, A., Schmid, R. M., et al. (2010) · Oncogene · doi:10.1038/onc.2010.46 · Cited by 149
Forkhead box M1 transcription factor: A novel target for cancer therapy
Wang, Z. P., Ahmad, A., Li, Y., Banerjee, S., Kong, D., & Sarkar, F. H. (2009) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2009.11.006 · Cited by 145
The NF-κB/AKT-dependent Induction of Wnt Signaling in Colon Cancer Cells by Macrophages and IL-1β
Kaler, P., Godasi, B. N., Augenlicht, L. H., & Klampfer, L. (2009) · Cancer Microenvironment · doi:10.1007/s12307-009-0030-y · Cited by 147
NF-κB oscillations translate into functionally related patterns of gene expression
Zambrano, S., Toma, I. D., Piffer, A., Bianchi, M. E., & Agresti, A. (2016) · eLife · doi:10.7554/elife.09100 · Cited by 149
NFKB1 and Cancer: Friend or Foe?
Concetti, J., & Wilson, C. L. (2018) · Cells · doi:10.3390/cells7090133 · Cited by 150
Short-chain fatty acids in cancer pathogenesis
Feitelson, M. A., Arzumanyan, A. L., Medhat, A., & Spector, I. (2023) · Cancer and Metastasis Reviews · doi:10.1007/s10555-023-10117-y · Cited by 151
Reactive oxygen species in melanoma and its therapeutic implications
Wittgen, H. G. M., & van Kempen, L. C. L. T. (2007) · Melanoma Research · doi:10.1097/cmr.0b013e3282f1d312 · Cited by 145
Mechanisms Linking Excess Adiposity and Carcinogenesis Promotion
Pérez-Hernández, A. I., Catalán, V., Gómez‐Ambrosi, J., RodrÃguez, A., & Frühbeck, G. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00065 · Cited by 148
Evaluating the Oxidative Stress in Inflammation: Role of Melatonin
Sánchez, A. B., Calpena, A. C., & Clares, B. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160816981 · Cited by 147
Emerging roles for the non-canonical IKKs in cancer
Shen, R. R., & Hahn, W. C. (2010) · Oncogene · doi:10.1038/onc.2010.493 · Cited by 148
Role of Epigenetics in Inflammation-Associated diseases
Shanmugam, M. K., & Sethi, G. (2013) · Subcellular Biochemistry · doi:10.1007/978-94-007-4525-4_27 · Cited by 141
Targeting inflammatory pathways for tumor radiosensitization
Deorukhkar, A., & Krishnan, S. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.06.039 · Cited by 143
Cell Survival and Apoptosis Signaling as Therapeutic Target for Cancer: Marine Bioactive Compounds
Kalimuthu, S., & Kim, S. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms14022334 · Cited by 145
Valilou, S. F., Keshavarz‐Fathi, M., Silvestris, N., Argentiero, A., & Rezaei, N. (2018) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2018.01.007 · Cited by 147
When dormancy fuels tumour relapse
Santos-de-Frutos, K., & Djouder, N. (2021) · Communications Biology · doi:10.1038/s42003-021-02257-0 · Cited by 153
Nuclear IKK activity leads to dysregulated Notch-dependent gene expression in colorectal cancer
Fernández‐Majada, V., Aguilera, C., Villanueva, A., Vilardell, F., Robert‐Moreno, A., Aytés, À., Real, F. X., Capellá, G., Mayo, M. W., Espinosa, L., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606476104 · Cited by 141
The Nuclear Factor κB pathway: A link to the immune system in the radiation response
Hellweg, C. E. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.02.019 · Cited by 143
Mukhtar, R. A., Nseyo, O., Campbell, M. J., & Esserman, L. J. (2010) · Expert Review of Molecular Diagnostics · doi:10.1586/erm.10.97 · Cited by 142
Endo, Y., Marusawa, H., Kou, T., Nakase, H., Fujii, S., Fujimori, T., Kinoshita, K., Honjo, T., & Chiba, T. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.06.091 · Cited by 148
Prakobwong, S., Gupta, S. C., Kim, J. H., Sung, B., Pinlaor, P., Hiraku, Y., Wongkham, S., Sripa, B., Pinlaor, S., & Aggarwal, B. B. (2011) · Carcinogenesis · doi:10.1093/carcin/bgr032 · Cited by 141
Inflammation, HCC and sex: IL-6 in the centre of the triangle
Prìeto, J. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.11.007 · Cited by 140
Human T Lymphotropic Virus Type 1 (HTLV-1): Molecular Biology and Oncogenesis
Kannian, P., & Green, P. L. (2010) · Viruses · doi:10.3390/v2092037 · Cited by 139
Muthuswamy, R., Berk, E., Junecko, B. A. F., Zeh, H. J., Zureikat, A. H., Normolle, D. P., Luong, T. M., Reinhart, T. A., Bartlett, D. L., & Kaliński, P. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-4136 · Cited by 140
Targeting of Nuclear Factor-κB and Proteasome by Dithiocarbamate Complexes with Metals
Cvek, B., & Dvořák, Z. (2007) · Current Pharmaceutical Design · doi:10.2174/138161207782110390 · Cited by 140
Indraccolo, S., Minuzzo, S. A., Masiero, M., Pusceddu, I., Persano, L., Moserle, L., Reboldi, A., Favaro, E., Mecarozzi, M., Mario, G. D., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2791 · Cited by 145
Koh, G. Y., Kane, A. V., Lee, K., Xu, Q., Wu, X., Roper, J., Mason, J. B., & Crott, J. W. (2018) · International Journal of Cancer · doi:10.1002/ijc.31559 · Cited by 137
A pervasive role of histone acetyltransferases and deacetylases in an NF-κB-signaling code
Calao, M., Burny, A., Quivy, V., Dekoninck, A., & Lint, C. M. V. (2008) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2008.04.015 · Cited by 144
Ah receptor and NF-κB interplay on the stage of epigenome
Tian, Y. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.10.023 · Cited by 144
Molecular Pathways: MERTK Signaling in Cancer
Cummings, C. T., DeRyckere, D., Earp, H. S., & Graham, D. K. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-1451 · Cited by 141
Bioactive dietary long-chain fatty acids: emerging mechanisms of action
Chapkin, R. S., McMurray, D. N., Davidson, L. A., Patil, B. S., Fan, Y., & Lupton, J. R. (2008) · British Journal Of Nutrition · doi:10.1017/s0007114508992576 · Cited by 138
The selectin–selectin ligand axis in tumor progression
Witz, I. P. (2008) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9101-z · Cited by 138
Nature or nurture: Let food be your epigenetic medicine in chronic inflammatory disorders
Szic, K. S. V., Ndlovu, ’. N., Haegeman, G., & Berghe, W. V. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.07.029 · Cited by 139
Li, C., Yang, Z., Zhai, C., Qiu, W., Li, D., Yi, Z., Wang, L., Tang, J., Qian, M., Luo, J., et al. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-73 · Cited by 136
Cancer chemoprevention through the induction of apoptosis by natural compounds
Kuno, T., Tsukamoto, T., Hara, A., & Tanaka, T. (2012) · Journal of Biophysical Chemistry · doi:10.4236/jbpc.2012.32018 · Cited by 136
Zhao, J., Li, D., Lu, B., Wu, G., Xu, D., Chen, J., Li, K., Tong, X., Dai, J., Yao, S., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.05.025 · Cited by 136
Regulation of Hypoxia‐Inducible Factors During Inflammation
Frede, S., Berchner‐Pfannschmidt, U., & Fandrey, J. (2007) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(07)35021-0 · Cited by 136
Genetic aspects of inflammation and cancer
Hold, G. L., & El-Omar, E. M. (2008) · Biochemical Journal · doi:10.1042/bj20071341 · Cited by 135
miRGen 2.0: a database of microRNA genomic information and regulation
Alexiou, P., Vergoulis, T., Gleditzsch, M., Prekas, G., Dalamagas, T., Megraw, M. S., Große, I., Sellis, T., & Hatzigeorgiou, A. G. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp888 · Cited by 134
Arora, S., Bhardwaj, A., Srivastava, S. K., Singh, S., McClellan, S. B., Wang, B., & Singh, A. P. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021573 · Cited by 134
Mitochondrial ROS – radical detoxification, mediated by protein kinase D
Störz, P. (2006) · Trends in Cell Biology · doi:10.1016/j.tcb.2006.11.003 · Cited by 134
Yamaguchi, N., Ito, T., Azuma, S., Ito, E., Honma, R., Yanagisawa, Y., Nishikawa, A., Kawamura, M., Imai, J., Watanabe, S., et al. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01228.x · Cited by 133
Immune System Evasion as Hallmark of Melanoma Progression: The Role of Dendritic Cells
Tucci, M., Passarelli, A. M., Mannavola, F., Felici, C., Stucci, L. S., Cives, M., & Silvestris, F. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.01148 · Cited by 139
Colon cancer, fatty acids and anti-inflammatory compounds
Chapkin, R. S., McMurray, D. N., & Lupton, J. R. (2006) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e32801145d7 · Cited by 134
Mitochondrial Cytochrome B Gene Mutation Promotes Tumor Growth in Bladder Cancer
Dasgupta, S., Hoque, M. O., Upadhyay, S. K., & Sidransky, D. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5532 · Cited by 133
Shankar, S., Ganapathy, S., & Srivastava, R. K. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0903 · Cited by 133
Ding, J., Huang, S., Wang, Y., Tian, Q., Zha, R., Shi, H., Wang, Q., Ge, C., Chen, T., Zhao, Y., et al. (2013) · Hepatology · doi:10.1002/hep.26378 · Cited by 132
Nerve Growth Factor in Cancer Cell Death and Survival
Molloy, N., Read, D. E., & Gorman, A. M. (2011) · Cancers · doi:10.3390/cancers3010510 · Cited by 141
Biotransformations and biological activities of hop flavonoids
Karabín, M., Hudcová, T., Jelínek, L., & Dostálek, P. (2015) · Biotechnology Advances · doi:10.1016/j.biotechadv.2015.02.009 · Cited by 144
Medeiros, R., Otuki, M. F., Avellar, M. C. W., & Calixto, J. Β. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.12.005 · Cited by 132
Harnessing the immune system to treat cancer
Bhardwaj, N. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32136 · Cited by 133
DEAD-box helicase DP103 defines metastatic potential of human breast cancers
Shin, E. M., Hay, H. S., Lee, M. H., Goh, J. N., Tan, T. Z., Sen, Y. P., Lim, S. W., Yousef, E. M., Ong, H. T., Thike, A. A., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci73451 · Cited by 132
A homeostatic model of IκB metabolism to control constitutive NF‐κB activity
O'Dea, E. L., Barken, D. M., Peralta, R. Q., Tran, K. T., Werner, S. L., Kearns, J. D., Levchenko, A., & Hoffmann, A. (2007) · Molecular Systems Biology · doi:10.1038/msb4100148 · Cited by 132
Growth Signals, Inflammation, and Vascular Perturbations
Hursting, S. D., & Hursting, M. J. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.241927 · Cited by 132
Koh, G. Y., Kane, A. V., Wu, X., & Crott, J. W. (2020) · Carcinogenesis · doi:10.1093/carcin/bgaa018 · Cited by 132
The atypical PKCs in inflammation: NF‐κB and beyond
Díaz-Meco, M. T., & Moscat, J. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2012.01093.x · Cited by 132
Barros, M. P., Poppe, S. C., & Bondan, E. F. (2014) · Nutrients · doi:10.3390/nu6031293 · Cited by 134
Ran, S., & Montgomery, K. E. (2012) · Cancers · doi:10.3390/cancers4030618 · Cited by 136
Exploiting Oxidative Microenvironments in the Body as Triggers for Drug Delivery Systems
Joshi-Barr, S., Lux, C. D. G., Mahmoud, E., & Almutairi, A. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5754 · Cited by 134
Role of advanced glycation end products in carcinogenesis and their therapeutic implications
Schröter, D., & Höhn, A. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666190130145549 · Cited by 126
Ding, D., Peng, X., Zhou, J., Wang, M., & Cong, Y. (2013) · The FASEB Journal · doi:10.1096/fj.13-230904 · Cited by 132
HO-1 underlies resistance of AML cells to TNF-induced apoptosis
Rushworth, S. A., & MacEwan, D. J. (2008) · Blood · doi:10.1182/blood-2007-07-104042 · Cited by 132
Nuclear IL-33 is a transcriptional regulator of NF-κB p65 and induces endothelial cell activation
Choi, Y.-S., Park, J. A., Kim, J., Rho, S.-S., Park, H., Kim, Y., & Kwon, Y. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.04.005 · Cited by 137
Many faces of NF-κB signaling induced by genotoxic stress
Wu, Z., & Miyamoto, S. (2007) · Journal of Molecular Medicine · doi:10.1007/s00109-007-0227-9 · Cited by 131
Mechanisms of action of isothiocyanates in cancer chemoprevention: an update
Navarro, S. L., Li, F., & Lampe, J. W. (2011) · Food & Function · doi:10.1039/c1fo10114e · Cited by 133
Purayil, H. T., & Kuttan, G. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.09.010 · Cited by 129
Paul, S., DeCastro, A., Lee, H. J., Smolarek, A. K., So, J. Y., Simi, B., Wang, C.-X., Zhou, R., Rimando, A. M., & Suh, N. (2010) · Carcinogenesis · doi:10.1093/carcin/bgq004 · Cited by 129
Unraveling the Anticancer Effect of Curcumin and Resveratrol
Pavan, A. R., Silva, G., Jornada, D. H., Chiba, D. E., Fernandes, G., Chin, C. M., & dos Santos, J. L. (2016) · Nutrients · doi:10.3390/nu8110628 · Cited by 130
Resveratrol Chemosensitizes TNF-β-Induced Survival of 5-FU-Treated Colorectal Cancer Cells
Buhrmann, C., Yazdi, M., Popper, B., Shayan, P., Goel, A., Aggarwal, B. B., & Shakibaei, M. (2018) · Nutrients · doi:10.3390/nu10070888 · Cited by 133
Sommermann, T. G., O’Neill, K. E., Plas, D. R., & Cahir-McFarland, E. D. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1715 · Cited by 129
Habib, S. L., & Rojna, M. (2013) · ISRN Oncology · doi:10.1155/2013/583786 · Cited by 131
Calorie restriction and cancer prevention: a mechanistic perspective
Hursting, S. D., Dunlap, S. M., Ford, N. A., Hursting, M. J., & Lashinger, L. M. (2013) · Cancer & Metabolism · doi:10.1186/2049-3002-1-10 · Cited by 137
Zhang, J., Späth, S. S., Marjani, S. L., Zhang, W., & Pan, X. (2018) · Precision Clinical Medicine · doi:10.1093/pcmedi/pby007 · Cited by 137
Cell-surface heparan sulfate proteoglycans as multifunctional integrators of signaling in cancer
Hassan, N., Greve, B., Espinoza‐Sánchez, N. A., & Götte, M. (2020) · Cellular Signalling · doi:10.1016/j.cellsig.2020.109822 · Cited by 129
Gene regulation by melatonin linked to epigenetic phenomena
Korkmaz, A., Rosales‐Corral, S., & Reiter, R. J. (2012) · Gene · doi:10.1016/j.gene.2012.04.040 · Cited by 132
Metadata
- Authors
- Karin, M.
- Affiliations
- University of California San Diego (US)
- Corresponding author
- Karin, Michael
- ORCID
- Karin, Michael
- Venue
- Nature
- Published
- 2006-05
- Volume
- 441
- Issue
- 7092
- Pages
- 431-436
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2315613727
- Cited by
- 3,519
- References
- 71
- Citations by year
- 2026: 60 · 2025: 97 · 2024: 111 · 2023: 118 · 2022: 118 · 2021: 159 · 2020: 162 · 2019: 133 · 2018: 168 · 2017: 149 · 2016: 192 · 2015: 235 · 2014: 203 · 2013: 231 · 2012: 250
- FWCI
- 15.68
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Health Sciences › Medicine › Complementary and alternative medicine › Natural Compounds in Disease Treatment
- Keywords
- NF-κB, carcinogenesis, tumor progression, inflammation and cancer, apoptosis resistance, tumor surveillance, tumor angiogenesis, tumour invasiveness, chemoprevention, chemotherapeutic target, NF-κB signaling
- MeSH terms
- Animals, Humans, Inflammation, Liver Neoplasms, Neoplasms, Skin Neoplasms, NF-kappa B, Disease Progression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review